No significant effect of SLCO1B1 polymorphism on the pharmacokinetics of rosiglitazone and pioglitazone

Annikka Kalliokoski, Mikko Neuvonen, Pertti J Neuvonen, Mikko Niemi

    Research output: Contribution to journalArticleScientificpeer-review

    Original languageEnglish
    JournalBritish Journal of Clinical Pharmacology
    Volume65
    Issue number1
    Pages (from-to)78-86
    Number of pages9
    ISSN0306-5251
    DOIs
    Publication statusPublished - 2008
    MoE publication typeA1 Journal article-refereed

    Cite this